Cipher Pharmaceuticals (TSE:CPH) Posts Earnings Results

Cipher Pharmaceuticals (TSE:CPH) (NASDAQ:CPHR) announced its quarterly earnings data on Thursday. The company reported C$0.33 earnings per share (EPS) for the quarter, FiscalAI reports. Cipher Pharmaceuticals had a net margin of 54.37% and a return on equity of 24.23%. The company had revenue of C$17.39 million during the quarter.

Cipher Pharmaceuticals Trading Up 10.5%

Shares of CPH stock opened at C$19.74 on Friday. Cipher Pharmaceuticals has a 52-week low of C$11.87 and a 52-week high of C$20.56. The company has a debt-to-equity ratio of 4.36, a quick ratio of 2.67 and a current ratio of 1.12. The stock has a market cap of C$499.05 million, a price-to-earnings ratio of 18.80 and a beta of 0.89. The firm has a fifty day moving average of C$17.24 and a 200-day moving average of C$15.54.

Cipher Pharmaceuticals Company Profile

Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America.